OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Rein in Big Pharma

Floor Speech

By: Ro Khanna
By: Ro Khanna
Date: Feb. 5, 2024
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. KHANNA. Mr. Speaker, for patients with leukemia, doctors often prescribe Imbruvica. In 2021, Johnson & Johnson and AbbVie sold it for a combined $10 billion.

Keytruda, a drug prescribed to cancer patients, netted Merck $20 billion; and Humira, a prescription drug for arthritis, allowed AbbVie to rake in $21 billion. This needs to stop.

Big Pharma is putting profits over people. They have three lobbyists for every one Member of Congress and have spent $370 million on lobbying while making excessive profits on the backs of cancer families.

That is why Senator Sanders and I have a bill to rein in prescription drug costs, and that is why I said let's ban PAC and lobbyist money. Americans shouldn't pay more for their drugs than the average price people in other countries are paying.

BREAK IN TRANSCRIPT


Source
arrow_upward